Table 1

Clinical demographics and characteristics of all the infants by outcome

All infants (n=57)
Median (IQR)
Normal outcome
(n=40)
Median (IQR)
Abnormal outcome
(n=17)
Median (IQR)
P value*
GA (weeks)28.9 (26.5–30.4)29.0 (26.6–30.5)28.6 (26.4–29.9)0.447
BW (g)1160 (850–1445)1185 (890–1563)1140 (625–1335)0.084
Apgar score 1 min7 (5–8)7 (5–8)6 (4–8)0.052
Apgar score 5 min8 (7–9)9 (7–9)8 (7–9)0.056
CRIB II7 (4–10)7 (3–10)8 (4–12)0.363
Initial pH7.23 (7.19–7.29)7.23 (7.18–7.28)7.24 (7.18–7.34)0.427
  n (%)   n (%)   n (%) P value
Gender
 Male35 (61)25 (63)10 (59)1
IUGR8 (14)3 (8)5 (29)0.043
Neuroimaging
 Normal34 (60)23 (58)11 (65)0.089
 IVH grade 1/216 (28)14 (35)2 (12)
 IVH grade 3/46 (11)3 (8)3 (18)
 cPVL1 (2)0 (0)1 (6)
Complications
 Sepsis27 (47)16 (40)11 (65)0.146
 Necrotising enterocolitis10 (18)7 (18)3 (18)1
 Chronic lung disease19 (33)13 (33)6 (35)1
 Retinopathy of prematurity2 (4)1 (3)1 (6)0.511
Medication
 AEDs2 (4)1 (3)1 (6)0.511
 Morphine4 (25)8 (20)6 (35)0.314
  • *Mann-Whitney U test.

  • †Fisher’s exact test.

  • AEDs, antiepileptic drugs (first-line AED of choice, administered intravenously as a loading dose of 20 mg/kg); BW, birth weight; cPVL, cystic periventricular leukomalacia; CRIB II, Clinical Risk Index for Babies II; GA, gestational age; IUGR, intrauterine growth restriction; IVH, intraventricular haemorrhage.